148 related articles for article (PubMed ID: 32287422)
1. A novel type of acyclic nucleoside phosphonates derived from 2-(phosphonomethoxy)propanoic acid.
Kaiser MM; Jansa P; Dračínský M; Janeba Z
Tetrahedron; 2012 May; 68(21):4003-4012. PubMed ID: 32287422
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.
Kaiser MM; Poštová-Slavětínská L; Dračínský M; Lee YJ; Tian Y; Janeba Z
Eur J Med Chem; 2016 Jan; 108():374-380. PubMed ID: 26706348
[TBL] [Abstract][Full Text] [Related]
3. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases.
Kaiser MM; Hocková D; Wang TH; Dračínský M; Poštová-Slavětínská L; Procházková E; Edstein MD; Chavchich M; Keough DT; Guddat LW; Janeba Z
ChemMedChem; 2015 Oct; 10(10):1707-23. PubMed ID: 26368337
[TBL] [Abstract][Full Text] [Related]
5. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.
Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252
[TBL] [Abstract][Full Text] [Related]
6. Enantiopurity analysis of new types of acyclic nucleoside phosphonates by capillary electrophoresis with cyclodextrins as chiral selectors.
Solínová V; Kaiser MM; Lukáč M; Janeba Z; Kašička V
J Sep Sci; 2014 Feb; 37(3):295-303. PubMed ID: 24259415
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of fluorinated acyclic nucleoside phosphonates with 5-azacytosine base moiety.
Pomeisl K; Krečmerová M; Pohl R; Snoeck R; Andrei G
Tetrahedron; 2019 Sep; 75(39):130529. PubMed ID: 32287433
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 by octadecyloxyethyl esters of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] nucleosides and evaluation of their mechanism of action.
Magee WC; Valiaeva N; Beadle JR; Richman DD; Hostetler KY; Evans DH
Antimicrob Agents Chemother; 2011 Nov; 55(11):5063-72. PubMed ID: 21896914
[TBL] [Abstract][Full Text] [Related]
9. Reshaping an Acyclic Nucleoside Phosphonate into a Selective Anti-hepatitis B Virus Compound.
Tan S; Groaz E; Kalkeri R; Ptak R; Korba BE; Herdewijn P
J Med Chem; 2022 Jul; 65(13):9396-9417. PubMed ID: 35754374
[TBL] [Abstract][Full Text] [Related]
10. Introduction of a cyano group at the 2-position of an (
Tan S; Groaz E; Prichard MN; Kalkeri R; Ptak R; Herdewijn P
RSC Med Chem; 2021 May; 12(5):804-808. PubMed ID: 34124679
[TBL] [Abstract][Full Text] [Related]
11. Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, and 2,6-diaminopurines.
Zídek Z; Potmesil P; Kmoníèková E; Holý A
Eur J Pharmacol; 2003 Aug; 475(1-3):149-59. PubMed ID: 12954371
[TBL] [Abstract][Full Text] [Related]
12. Secretion of antiretroviral chemokines by human cells cultured with acyclic nucleoside phosphonates.
Zídek Z; Kmonícková E; Holý A
Eur J Pharmacol; 2007 Nov; 574(1):77-84. PubMed ID: 17716649
[TBL] [Abstract][Full Text] [Related]
13. Acyclic nucleotide analogs derived from 8-azapurines: synthesis and antiviral activity.
Holý A; Dvoráková H; Jindrich J; Masojídková M; Budĕsínský M; Balzarini J; Andrei G; De Clercq E
J Med Chem; 1996 Sep; 39(20):4073-88. PubMed ID: 8831773
[TBL] [Abstract][Full Text] [Related]
14. Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates.
Balzarini J; Pannecouque C; De Clercq E; Aquaro S; Perno CF; Egberink H; Holý A
Antimicrob Agents Chemother; 2002 Jul; 46(7):2185-93. PubMed ID: 12069973
[TBL] [Abstract][Full Text] [Related]
15. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
Aduma P; Connelly MC; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
[TBL] [Abstract][Full Text] [Related]
16. Chiral analysis of anti-acquired immunodeficiency syndrome drug, 9-(R)-[2-(phosphonomethoxy)propyl]adenine (tenofovir), and related antiviral acyclic nucleoside phosphonates by CE using beta-CD as chiral selector.
Solínová V; Kasicka V; Sázelová P; Holý A
Electrophoresis; 2009 Jun; 30(12):2245-54. PubMed ID: 19544492
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP
Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648
[TBL] [Abstract][Full Text] [Related]
18. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
19. Involvement of adenosine A1 receptors in upregulation of nitric oxide by acyclic nucleotide analogues.
Zídek Z; Kmonícková E; Holý A
Eur J Pharmacol; 2004 Oct; 501(1-3):79-86. PubMed ID: 15464065
[TBL] [Abstract][Full Text] [Related]
20. Acyclic nucleoside phosphonates with 5-azacytosine base moiety substituted in C-6 position.
Krecmerová M; Masojídková M; Holý A
Bioorg Med Chem; 2010 Jan; 18(1):387-95. PubMed ID: 19914075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
